PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of jrsocmedLink to Publisher's site
 
J R Soc Med. 1985 December; 78(12): 985–994.
PMCID: PMC1290051

Measurement of outcome in rheumatic diseases.

Abstract

In the assessment of outcome in rheumatic diseases a number of factors must be taken into account. It is important to make an accurate diagnosis, so that the response to treatment is not confused by heterogeneity of the population. The meaning of outcome needs to be defined. The quality of life over a prolonged period is just as important as the ultimate outcome. Subjective symptoms are important to the patient. Pain is the most important, followed by disability and then stiffness. Despite attempts to produce numerical values for pain, particularly visual analogue scales, patients' accuracy in recalling pain experienced more than an hour previously is dubious. In an attempt to quantify this aspect we have measured disturbance of sleep by changes in the EEG and in the motility of the patient. Objective clinical measures are desirable for accuracy. Arthrographs of the knees and metacarpophalangeal joints have produced useful data for physical stiffness. It is doubtful, however, whether they truly reflect the subjective stiffness of which the patient complains. That is more likely to be due to limitation of motion. Grip strength is commonly measured by a pneumatic dynomometer, but a pinch/hand grip analyser promises to give more extensive information. Active movement has been measured goniometrically. The value of electrogoniometers should be enhanced by telemeterization of the apparatus. Passive movement has been measured with a hyperextensometer in patients with hypermobility. Ligamentous laxity of the knee can be measured on the Leeds Knee Analyser and differentiates collateral ligament damage and anterior cruciate ligament damage. Laboratory variables are important in a patient model system in which potential antirheumatoid drugs can be screened and their mechanism of action investigated. Correlation matrices separate second-line agents from NSAIDs. Although mini-matrices have been produced, it would not appear that any single biochemical test will suffice to differentiate these two classes of drugs. A therapeutic index, in which the efficacy is expressed as a ratio of the toxicity of the drug, is important in determining its value. The nearest we can get to serial assessment of the pathological changes in the joint is by X-ray assessment. Changes radiologically correlate to some extent with the height of the ESR, and their progress with changes in the ESR. Functional impairment is important to the patient in the long term, and the Disability Index devised by the Stanford group commends itself for extensive long-term studies.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.1M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Barnett CH, Cobbold AF. Effects of age upon the mobility of human finger joints. Ann Rheum Dis. 1968 Mar;27(2):175–177. [PMC free article] [PubMed]
  • Bird HA, Esselinckx W, Dixon AS, Mowat AG, Wood PH. An evaluation of criteria for polymyalgia rheumatica. Ann Rheum Dis. 1979 Oct;38(5):434–439. [PMC free article] [PubMed]
  • Buckland-Wright JC. X-ray assessment of activity in rheumatoid disease. Br J Rheumatol. 1983 Feb;22(1):3–10. [PubMed]
  • Dixon JS, Bird HA. Reproducibility along a 10 cm vertical visual analogue scale. Ann Rheum Dis. 1981 Feb;40(1):87–89. [PMC free article] [PubMed]
  • Dixon JS, Bird HA, Surrall KE, Sitton NG, Wright V. A comparison of therapies which may influence trace metals in rheumatoid arthritis. Clin Rheumatol. 1984 Dec;3(4):451–457. [PubMed]
  • ELLMAN P, BALL RE. Rheumatoid disease with joint and pulmonary manifestations. Br Med J. 1948 Nov 6;2(4583):816–820. [PMC free article] [PubMed]
  • Fries JF, Spitz P, Kraines RG, Holman HR. Measurement of patient outcome in arthritis. Arthritis Rheum. 1980 Feb;23(2):137–145. [PubMed]
  • Grahame R, Jenkins JM. Joint hypermobility--asset or liability? A study of joint mobility in ballet dancers. Ann Rheum Dis. 1972 Mar;31(2):109–111. [PMC free article] [PubMed]
  • Hicklin JA, Wighton RJ, Robinson FJ. Measurement of finger stiffness. Ann Phys Med. 1968 May;9(6):234–242. [PubMed]
  • Howe A, Thompson D, Wright V. Microprocessor controlled arthrograph. J Biomed Eng. 1985 Apr;7(2):153–156. [PubMed]
  • Huskisson EC. Measurement of pain. Lancet. 1974 Nov 9;2(7889):1127–1131. [PubMed]
  • Jaffe IA. The use of slow-acting drugs in rheumatoid arthritis. Scand J Rheumatol. 1984;13(4):377–378. [PubMed]
  • Kirwan JR, Chaput de Saintonge DM, Joyce CR, Currey HL. Clinical judgment in rheumatoid arthritis. II. Judging 'current disease activity' in clinical practice. Ann Rheum Dis. 1983 Dec;42(6):648–651. [PMC free article] [PubMed]
  • LANSBURY J. Report of a three-year study on the systemic and articular indexes in rheumatoid arthritis; theoretic and clinical considerations. Arthritis Rheum. 1958 Dec;1(6):505–522. [PubMed]
  • McGuire RJ, Wright V. Statistical approach to indices of disease activity in rheumatoid arthritis. Ann Rheum Dis. 1971 Nov;30(6):574–580. [PMC free article] [PubMed]
  • Neumann VC, Grindulis KA, Hubball S, McConkey B, Wright V. Comparison between penicillamine and sulphasalazine in rheumatoid arthritis: Leeds-Birmingham trial. Br Med J (Clin Res Ed) 1983 Oct 15;287(6399):1099–1102. [PMC free article] [PubMed]
  • O'Brien WM. Indomethacin: a survey of clinical trials. Clin Pharmacol Ther. 1968 Jan-Feb;9(1):94–107. [PubMed]
  • Panayi GS, Wooley P, Batchelor JR. Genetic basis of rheumatoid disease: HLA antigens, disease manifestations, and toxic reactions to drugs. Br Med J. 1978 Nov 11;2(6148):1326–1328. [PMC free article] [PubMed]
  • Ritchie DM, Boyle JA, McInnes JM, Jasani MK, Dalakos TG, Grieveson P, Buchanan WW. Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. Q J Med. 1968 Jul;37(147):393–406. [PubMed]
  • 1958 REVISION of diagnostic criteria for rheumatoid arthritis. Arthritis Rheum. 1959 Feb;2(1):16–20. [PubMed]
  • SCOTT JT. Morning stiffness in rheumatoid arthritis. Ann Rheum Dis. 1960 Dec;19:361–368. [PMC free article] [PubMed]
  • Unsworth A, Bey PM, Haslock I. Stiffness in the metacarpo-phalangeal joints of young adults. Clin Phys Physiol Meas. 1981 May;2(2):123–133. [PubMed]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press